BEECHWOOD SURGERY — All Prescriptions & Medications — Page 11
Practice Code: F81023 | BRENTWOOD, CM14 5WF
Showing results 501-550 of 576
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 15 | 123 | £784 | -26.9% ▼ | |
| 15 | 920 | £3.3K | -38.4% ▼ | |
| Prucalopride | 14 | 896 | £382 | -64.0% ▼ |
| Acrivastine | 14 | 1,104 | £325 | +13.7% ▲ |
| Ondansetron hydrochloride | 14 | 328 | £194 | -71.1% ▼ |
| Co-trimoxazole(Trimethoprim/sulfamethoxazole) | 14 | 968 | £129 | -65.2% ▼ |
| Quinine bisulfate | 14 | 784 | £145 | -63.9% ▼ |
| Tamsulosin and dutasteride hydrochloride | 14 | 660 | £193 | -59.9% ▼ |
| Potassium chloride | 14 | 1,200 | £649 | -25.1% ▼ |
| Fusidic acid | 14 | 70 | £259 | +35.5% ▲ |
| Menthol | 14 | 7,000 | £252 | -50.3% ▼ |
| Permethrin | 14 | 690 | £186 | -62.8% ▼ |
| 14 | 160 | £336 | +58.2% ▲ | |
| 14 | 26 | £3.7K | +60.8% ▲ | |
| 14 | 730 | £580 | -65.5% ▼ | |
| Amiloride hydrochloride | 13 | 364 | £179 | -48.4% ▼ |
| Cilostazol | 13 | 728 | £436 | -6.3% ▼ |
| Formoterol/glycopyrronium/budesonide | 13 | 13 | £550 | -78.4% ▼ |
| Trimipramine maleate | 13 | 728 | £3.3K | -18.4% ▼ |
| Cinnarizine | 13 | 1,050 | £116 | -72.2% ▼ |
| Testosterone esters | 13 | 13 | £30 | -11.9% ▼ |
| Cyproterone acetate | 13 | 364 | £425 | +18.4% ▲ |
| Powder lactose free formula (0913105) | 13 | 58.4K | £896 | +61.9% ▲ |
| Atropine sulfate | 13 | 260 | £214 | +2.0% ▲ |
| Fludroxycortide | 13 | 72 | £295 | +23.3% ▲ |
| Clindamycin phosphate | 13 | 420 | £100 | -21.0% ▼ |
| Isosorbide dinitrate | 12 | 672 | £196 | -33.3% ▼ |
| Oxazepam | 12 | 360 | £40 | -43.7% ▼ |
| Trihexyphenidyl hydrochloride | 12 | 336 | £17 | -57.7% ▼ |
| Choriogonadotropin alfa | 12 | 48 | £1.8K | +162.1% ▲ |
| Ergocalciferol | 12 | 684 | £177 | -28.3% ▼ |
| Powder 20g GMP protein equivalent (0913205) | 12 | 720 | £10.5K | +24.3% ▲ |
| Ready to serve 15g GMP protein equivalent (0913205) | 12 | 315 | £3.6K | +20.9% ▲ |
| 12 | 260 | £713 | -23.5% ▼ | |
| 12 | 12 | £271 | -82.5% ▼ | |
| 12 | 2,160 | £3.7K | -43.3% ▼ | |
| 12 | 501 | £107 | -75.7% ▼ | |
| 12 | 36 | £391 | +18.2% ▲ | |
| 12 | 1,240 | £307 | -18.4% ▼ | |
| 12 | 8,640 | £330 | +33.5% ▲ | |
| 12 | 2,700 | £334 | -9.0% ▼ | |
| 12 | 630 | £1.3K | -26.5% ▼ | |
| 12 | 225 | £793 | +36.9% ▲ | |
| Methyldopa | 11 | 616 | £79 | -35.4% ▼ |
| Indacaterol/glycopyrronium | 11 | 330 | £340 | -75.6% ▼ |
| Mometasone/glycopyrronium/indacaterol | 11 | 420 | £592 | -27.4% ▼ |
| Codeine phosphate | 11 | 2,200 | £45 | -23.4% ▼ |
| Imipramine hydrochloride | 11 | 616 | £23 | -56.9% ▼ |
| Stiripentol | 11 | 660 | £4.3K | -8.3% ▼ |
| Perampanel | 11 | 616 | £2.9K | -49.2% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.